Matter of Burka, Misc. Civ. No. 88-0003.
Court | United States District Courts. 3th Circuit. United States District Court (Eastern District of Pennsylvania) |
Writing for the Court | RAYMOND J. BRODERICK |
Citation | 684 F. Supp. 1300 |
Docket Number | Misc. Civ. No. 88-0003. |
Decision Date | 09 May 1988 |
Parties | In the Matter of Edward R. BURKA, M.D., United States Department of Justice, Drug Enforcement Administration. |
684 F. Supp. 1300
In the Matter of Edward R. BURKA, M.D., United States Department of Justice, Drug Enforcement Administration.
Misc. Civ. No. 88-0003.
United States District Court, E.D. Pennsylvania.
May 9, 1988.
Ralph J. Caccia, Stephen V. Wehner, Santarelli, Smith, Kraut and Carroccio, Washington, D.C., for petitioner Burka.
Edward S.G. Dennis, Jr., U.S. Atty., Serena H. Dobson, Asst. U.S. Atty., Philadelphia, Pa., for defendant Drug Enforcement Admin.
MEMORANDUM
RAYMOND J. BRODERICK, District Judge.
On May 5, 1987, Magistrate William Hall of the United States District Court for the Eastern District of Pennsylvania issued, pursuant to 21 U.S.C. § 880(d)(1), Administrative Inspection Warrant 87-692-M, authorizing the Drug Enforcement Administration ("DEA") to inspect the medical office of Edward R. Burka, M.D. An administrative inspection and audit of Dr. Burka's office and medical records was conducted during the period May 5, 1987 through June 3, 1987. Based upon the results of the inspection and audit, the DEA Administrator, on September 2, 1987, issued an Order to Show Cause why Dr. Burka's registration should not be permanently revoked on the ground that such registration was inconsistent with the public interest, as determined pursuant to 21 U.S.C. §§ 823(f) and 824(a)(4). Simultaneously with the issuance of the Show Cause Order, the Administrator temporarily suspended Dr. Burka's registration until a "final determination" is reached in the revocation proceedings, pursuant to 21 U.S. C. § 824(d). The Administrator preliminarily concluded that Dr. Burka's continued registration, during the pendency of the revocation proceedings, would constitute an imminent danger to the public health and safety. See 21 C.F.R. § 1301.46. Pursuant to 21 C.F.R. § 1301.46(a), the DEA Administrator provided a statement of the findings regarding the danger to the public health or safety which resulted in the decision to temporarily suspend Dr. Burka's registration:
1. That Dr. Burka did not maintain required records for the ordering and dispensation of certain Schedule II controlled substances.
2. That the DEA interviewed individuals to whom Dr. Burka allegedly dispensed certain controlled substances and that these individuals stated that controlled substances were never dispensed to them.
3. That the DEA interviewed individuals and physicians who worked in Dr. Burka's office and that these individuals stated they had no knowledge of any dispensing of controlled substances.
4. That subsequent to a DEA investigation conducted in May and June, 1987 and the execution of a search warrant in August 1987, Dr. Burka continued to order certain Schedule II controlled substances.
On January 8, 1988, Dr. Burka petitioned this Court, pursuant to 21 U.S.C. § 824(d) to dissolve the DEA suspension of his DEA registration on the ground that (1) no admissible evidence existed to support the finding made by the DEA Administrator that Dr. Burka's continued registration posed an imminent danger to the public health and safety, and (2) in the absence of such a legal finding, the DEA violated Dr. Burka's constitutional right to procedural due process by suspending his registration without providing Dr. Burka with either prior notice or an opportunity for a hearing as to the temporary suspension. Subsequently, on February 8, 1988, Dr. Burka moved this Court to suppress all evidence derived from the execution of Administrative Inspection Warrant 87-692-M on the ground that inasmuch as the affidavit submitted in support of the request for the warrant failed to establish a probable cause, the issuance of the warrant by the United States Magistrate violated Dr. Burka's Fourth Amendment rights.
For the reasons stated below, this Court finds that probable cause did exist for the
I.
The Comprehensive Drug Abuse Prevention and Control Act of 1970, 21 U.S.C. § 801, et seq. ("Act") established a closed system of drug distribution for legitimate handlers of controlled substances. The statute attempts to control the flow of controlled substances through registration of and record keeping by all those within the "legitimate distributional chain", and prohibition of all transactions outside that chain. See U.S.Code Cong. & Admin.News 4566, 4569 (1970). Thus, the Act requires those who manufacture, distribute, import, export, dispense, and/or administer controlled substances to register with the Attorney General, 21 U.S.C. §§ 822-823, and adhere to certain record keeping and reporting requirements. 21 U.S.C. § 827, 21 C.F.R. § 1304.01, et seq. Manufacturers, distributors and wholesalers of controlled substances are required to file records of sales to physicians and other medical practitioners with the DEA Automation of Reports and Consolidated Orders System ("ARCOS") unit in Washington, D.C. 21 C.F.R. § 1304. The ARCOS unit, in turn, identifies those physicians and other medical practitioners who have purchased large quantities of controlled substances through the issuance of Excessive Purchase Reports.
The Act also authorizes the DEA to conduct periodic inspections of the establishments of those required to register with the Attorney General. 21 U.S.C. § 822(f). DEA regulations evidence an intent by the Agency to conduct such inspections at least once every three years. 21 C.F.R. § 1316.13. In addition, the Act authorizes administrative inspections of "controlled premises," e.g. places where original or other records or documents required thereunder are kept or are required to be kept, pursuant to an applicable inspection warrant. 21 U.S.C. § 880(a) and (b). The statute defines the level of "probable cause" required for the issuance of an administrative inspection warrant:
... For purposes of this section, the term "probable cause" means a valid public interest in the effective enforcement of this subchapter or regulations thereunder sufficient to...
To continue reading
Request your trial-
Neil Laboratories, Inc. v. Ashcroft, Civil Action No. 02-0428 (RMU).
...substances through registration of and record keeping by all those within the `legitimate distributional chain'...." In re Burka, 684 F.Supp. 1300, 1302 (E.D.Pa.1988). In an attempt to curtail the diversion of chemicals used for the illicit manufacture of controlled substances, the CSA......
-
US v. Burka, Crim. A. No. 88-00228-01.
...have upheld administrative inspections of physicians' offices on grounds similar to those presented in this case. See Matter of Burka, 684 F.Supp. 1300 (E.D.Pa.1988) (court upheld probable cause determination on identical grounds in a related case);1 United States v. Montrom, 345 F.Supp. 13......
-
Neil Laboratories, Inc. v. Ashcroft, Civil Action No. 02-0428 (RMU).
...substances through registration of and record keeping by all those within the `legitimate distributional chain'...." In re Burka, 684 F.Supp. 1300, 1302 (E.D.Pa.1988). In an attempt to curtail the diversion of chemicals used for the illicit manufacture of controlled substances, the CSA......
-
US v. Burka, Crim. A. No. 88-00228-01.
...have upheld administrative inspections of physicians' offices on grounds similar to those presented in this case. See Matter of Burka, 684 F.Supp. 1300 (E.D.Pa.1988) (court upheld probable cause determination on identical grounds in a related case);1 United States v. Montrom, 345 F.Supp. 13......